Journal of Molecular Medicine

, Volume 88, Issue 4, pp 431–436

Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease

  • Larissa Arning
  • Aiden Haghikia
  • Elahe Taherzadeh-Fard
  • Carsten Saft
  • Jürgen Andrich
  • Bartoz Pula
  • Stefan Höxtermann
  • Stefan Wieczorek
  • Denis Amer Akkad
  • Moritz Perrech
  • Ralf Gold
  • Jörg Thomas Epplen
  • Andrew Chan
Original article

DOI: 10.1007/s00109-010-0589-2

Cite this article as:
Arning, L., Haghikia, A., Taherzadeh-Fard, E. et al. J Mol Med (2010) 88: 431. doi:10.1007/s00109-010-0589-2

Abstract

Mitochondrial dysfunction has been implicated in the pathogenesis of Huntington disease (HD), a primarily neurodegenerative disorder that results from an expansion in the polymorphic trinucleotide CAG tract in the HD gene. In order to evaluate whether mitochondrial DNA (mtDNA) variation contributes to HD phenotype we genotyped 13 single nucleotide polymorphisms (SNPs) that define the major European mtDNA haplogroups in 404 HD patients. Genotype-dependent functional effects on intracellular ATP concentrations were assessed in peripheral leukocytes. In patients carrying the most common haplogroup H (48.3%), we demonstrate a significantly lower age at onset (AO). In combination with PGC-1alpha genotypes, 3.8% additional residual variance in HD AO can be explained. Intracellular ATP concentrations in HD patients carrying the cytochrome c oxidase subunit I (CO1) 7028C allele defining haplogroup H were significantly higher in comparison to non-H individuals (mean ± SEM, 599 ± 51.8 ng/ml, n = 14 vs. 457.5 ± 40.4 ng/ml, p = 0.03, n = 9). In contrast, ATP concentrations in cells of HD patients independent from mtDNA haplogroup showed no significant differences in comparison to matched healthy controls. Our data suggest that an evolutionarily advantageous mitochondrial haplogroup is associated with functional mitochondrial alterations and may modify disease phenotype in the context of neurodegenerative conditions such as HD.

Keywords

Huntington diseaseAge at onsetmtDNA haplogroupsATP

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Larissa Arning
    • 1
  • Aiden Haghikia
    • 2
  • Elahe Taherzadeh-Fard
    • 1
  • Carsten Saft
    • 2
  • Jürgen Andrich
    • 2
  • Bartoz Pula
    • 2
  • Stefan Höxtermann
    • 3
  • Stefan Wieczorek
    • 1
  • Denis Amer Akkad
    • 1
  • Moritz Perrech
    • 2
  • Ralf Gold
    • 2
  • Jörg Thomas Epplen
    • 1
  • Andrew Chan
    • 2
  1. 1.Department of Human GeneticsRuhr-UniversityBochumGermany
  2. 2.Department of Neurology, St. Josef HospitalRuhr-UniversityBochumGermany
  3. 3.Department of Dermatology, St. Josef HospitalRuhr-UniversityBochumGermany